文献速递帕金森病与运动障碍认知障碍与痴呆

特发性快速眼动睡眠行为障碍的病例-对照-家系研究

A case-control-family study of idiopathic rapid eye movement sleep behavior disorder.
PubMed 文献 · Ann Neurol · 2019-03-19

研究纳入102例iRBD患者和89名对照的一级亲属,分别有404名和387名亲属参与。患者亲属的RBD特征、帕金森病、痴呆、便秘及运动功能障碍风险均高于对照亲属,提示iRBD存在家族聚集性,且α-突触核蛋白病具有家族聚集和分期病理特征。

要点

  • iRBD患者一级亲属的RBD特征和确诊RBD风险显著高于对照亲属。
  • 患者亲属的帕金森病、痴呆、便秘和运动功能障碍风险升高。
  • 未患病亲属的前驱期帕金森病似然比更高,提示α-突触核蛋白病家族聚集。

核心结论

  • iRBD从孤立特征到完整睡眠障碍均呈现家族聚集性。
  • 患者亲属在神经退行性疾病和前驱标志物方面具有更高的α-突触核蛋白病风险,提示α-突触核蛋白病的家族聚集和分期病理。

研究设计与样本

  • 病例-对照-家系研究,招募102例iRBD患者和89名对照的一级亲属,分别为404名和387名。
  • 其中204名患者亲属和208名对照亲属接受面对面临床评估,97名患者亲属和75名对照亲属接受视频多导睡眠图评估。

主要发现

  • 患者亲属的下颌紧张性肌电活动均值1.5±7.5 vs 0.3±1.0,p=0.04;行为事件12例(加权11.3%)vs 2例(1.9%),aHR=7.69,95%CI=1.54-33.33,p=0.009。
  • probable诊断57例(14.9%)vs 20例(4.9%),aHR=3.45,95%CI=1.96-6.25,p<0.001;definite诊断10例(加权8.4%)vs 2例(1.4%),aHR=5.56,95%CI=1.16-25.00,p=0.03。
  • 帕金森病风险3.1% vs 0.5%,aHR=5.88,95%CI=1.37-25.00,p=0.02;痴呆风险6.9% vs 2.6%,aHR=2.44,95%CI=1.15-5.26,p=0.02。
  • 便秘风险8.3% vs 2.4%,调整OR=4.21,95%CI=1.34-13.17,p=0.01;MDS-UPDRS part III运动评分均值1.9±3.2 vs 0.9±2.3,p=0.002。
  • 未患病亲属的前驱期帕金森病似然比中位数0.27(IQR 1.19)vs 0.22(IQR 0.51),p=0.03。

临床怎么用

  • 对iRBD患者的一级亲属应关注RBD症状、帕金森病、痴呆、便秘及运动功能障碍等前驱标志物。
  • 家族聚集性提示iRBD亲属可能处于α-突触核蛋白病不同阶段,需长期随访评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the familial aggregation of idiopathic rapid eye movement sleep behavior disorder (iRBD), neurodegenerative diseases, and related biomarkers. METHODS: A total of 404 and 387 first-degree relatives of 102 patients with iRBD and of 89 controls were recruited, respectively. Among them, 204 and 208 relatives of patients and controls underwent face-to-face clinical assessment, whereas 97 and 75 relatives underwent further video-polysomnographic assessment, respectively. RESULTS: Compared with relatives of controls, relatives of patients demonstrated higher levels of RBD features, including chin tonic electromyography activity (mean = 1.5 ± 7.5 vs 0.3 ± 1.0, p = 0.04) and behavioral events (n [weighted %] = 12 [11.3] vs 2 [1.9], adjusted hazard ratio [aHR] = 7.69, 95% confidence interval [CI] = 1.54-33.33, p = 0.009) during rapid eye movement sleep, probable diagnosis (n [%] = 57 [14.9] vs 20 [4.9], aHR = 3.45, 95% CI = 1.96-6.25, p < 0.001), and definite diagnosis (n [weighted %] = 10 [8.4] vs 2 [1.4], aHR = 5.56, 95% CI = 1.16-25.00, p = 0.03). They also had higher risks of Parkinson disease (3.1% vs 0.5%, aHR = 5.88, 95% CI = 1.37-25.00, p = 0.02), dementia (6.9% vs 2.6%, aHR = 2.44, 95% CI = 1.15-5.26, p = 0.02), constipation (8.3% vs 2.4%, adjusted odds ratio = 4.21, 95% CI = 1.34-13.17, p = 0.01), and motor dysfunction (Movement Disorders Society Unified Parkinson's Disease Rating Scale part III motor score, mean = 1.9 ± 3.2 vs 0.9 ± 2.3, p = 0.002). The unaffected relatives of patients demonstrated a higher likelihood ratio of prodromal Parkinson disease (median [interquartile range] = 0.27 [1.19] vs 0.22 [0.51], p = 0.03). INTERPRETATION: iRBD is familially aggregated from isolated features to full-blown sleep disorder. Relatives of patients carry a higher risk of alpha-synucleinopathy in terms of neurodegenerative diseases and prodromal markers, suggesting a familial aggregation and staging pathology of alpha-synucleinopathy. Ann Neurol 2019;85:582-592.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Zhang J, Lam SP, et al. A case-control-family study of idiopathic rapid eye movement sleep behavior disorder. Ann Neurol. 2019. PMID: 30761606. doi:10.1002/ana.25435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。